Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-20-011485)

Filing Details

Accession Number:: 0001437749-20-011485
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-05-20 21:24:18
Reporting Period:: 2019-07-05

Accepted Time:: 2020-05-20 21:24:18
Original Submission Date:: 2019-08-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
925741	Biocardia Inc.	BCDA;BCDAW	Biological Products, (No Disgnostic Substances) (2836)	232753988

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1031689	H Simon Stertzer	C/O Biocardia, Inc. 125 Shoreway Road, Suite B San Carlos CA 94070		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-02	41,667	$6.00	91,544	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2019-08-02	41,667	$0.00	41,667	$6.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
41,667	2019-08-06	2024-08-06	No	4	P	Indirect

Footnotes

The original Form 4 omitted the issuance of these securities.
The reported securities were included within 41,667 units purchased by Stertzer Holdings LLC for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock.
These securities are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such securities.